New scanner could help surgeons spot Left-Behind cancer Mid-Operation
NCT ID NCT06676943
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new type of PET-CT scanner that can scan a tumor right after it is removed from the body. Patients with prostate or head and neck cancer received a small amount of radioactive tracer before surgery, which sticks to cancer cells. After removal, the specimen was scanned to see if cancer cells reached the edge (margin). The scan results were compared to standard lab tests to see how accurate the new method is. If it works well, surgeons could use it during operations to make sure they remove all the cancer the first time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
radioactive tracer (fluorodeoxyglucose or similar) injected before surgery
What this could lead to
If successful, this technique could help surgeons see during an operation whether they have removed all the cancer, reducing the need for extra treatments or second surgeries.
What could go wrong
This is a small pilot study with only 57 participants, so results may not apply to all cancer types. The scanner's accuracy needs to be confirmed against standard lab tests, and it may not work for all tumor locations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Hospitals Coventry and Warwickshire NHS Trust
Coventry, CV2 2DX, United Kingdom